The effect of school and adult vaccination on susceptibility to rubella in women of childbearing age was assessed in the Manchester area, where the population attending antenatal clinics is over 40 000 a year. Between 1979 and 1984 the proportion susceptible fell from 6-4% to 2-7%. In 1984, 4-2% of nulliparous women were susceptible compared with 1-4% of women in their second or subsequent pregnancy. Eighty five per cent of pregnant women screened and found to be non-immune were vaccinated post partum before leaving hospital. Requests for prevaccination screening of non-pregnant women increased in response to a national campaign and at the time of local outbreaks of rubella but only two thirds of those found to be nonimmune were subsequently vaccinated. During 1983 and 1984 infection was confirmed in 57 pregnant women-2% of those non-immune.
Introduction
Selective vaccination of schoolgirls against rubella began in the United Kingdom in 1970' with the ultimate aim of eliminating congenital rubella syndrome.2' In 1972 vaccination after serological screening was also offered to women of childbearing age before pregnancy or after delivery.4 In 1976 acceptance of vaccine by schoolgirls in England and Wales was only 72%5; vaccination figures for adult women were unknown. A widespread outbreak of rubella in 1978-9 resulted in 124 notified cases of congenital rubella syndrome6 and 1405 terminations for rubella7 '-a sixfold rise from . As a consequence doctors were urged to increase the uptake of vaccination,9 and by 1980 acceptance at school age had risen to 84%. "' Concern about the impending outbreak of rubella in spring 1983 prompted further action by the Department of Health and Social Security," " and in November 1983 a campaign was launched with widespread publicity to increase both adult and school vaccination over a period of three years.2 13 A study coordinated by the then Epidemiological Research Laboratory (now the Communicable Disease Surveillance Centre) of the Public Health Laboratory Service (PHLS) was set up to assess the impact already made by rubella vaccination on the susceptibility of women of childbearing age and to monitor future changes resulting from the campaign.
In Britain screening for rubella antibody is part of the routine antenatal examination, and in most areas women are screened in each pregnancy irrespective of past immunity or vaccination. The effects of school, prepregnancy, and postpartum vaccination were assessed by comparing susceptibility among pregnant women with that of men in the same age groups. Since non-pregnant women are also screened before vaccination the immediate effect of the campaign was monitored by recording the number of these requests before and after the campaign began. The overall value of screening pregnant and non-pregnant women was assessed by checking the proportion of non-immune women who were subsequently vaccinated. The incidence of confirmed rubella in the population of pregnant women was measured using the laboratory results of diagnostic investigations for rubella.
The study began in Greater Manchester in January 1984 and in PHLS laboratories in Ashford, Bristol, Gloucester, Hereford, Leeds, Luton, and Reading during the year. The total number of serum samples tested for rubella in these laboratories in 1984 was roughly 170 
SCREENING OF NON-PREGNANT WOMEN
In 1984 a total of 11 415 serum samples from non-pregnant women were screened by the Manchester Public Health Laboratory and North Manchester Regional Virus Laboratory. Of these, 41% were routine pre-employment screens requested by occupational health clinics, 32% came from general practitioners, 8% from family planning clinics, and 19% from other sources including gynaecology wards and infertility clinics. Of the 4741 Information on parity was available for 18 616 women screened, of whom 56% were parous. In all 1-4% of parous women were seronegative compared with 4-2% of nulliparous women and 8 6% of men. The difference between parous and nulliparous women was highly significant in all age groups (fig 1) . Within each parity group the proportion seronegative did not vary with age. In parous women there was no difference between those in their second and those in subsequent pregnancies. In all age groups the proportion of men who were seronegative was higher than that of nulliparous women; the difference was most pronounced (threefold) in the under 20 age group. samples from occupational health clinics, only 181 (3 8%) were seronegative. By contrast, of the 6674 samples received from general practitioners, family planning clinics, or other sources, 555 (8 3%) were seronegative-nearly three times the proportion in the samples from pregnant women (table II) . The proportion of non-pregnant women who were seronegative showed little variation with age and remained constant irrespective of the numbers screened each month.
The number of requests for prevaccination screening (other than from occupational health clinics) rose in the summer of 1983, when rubella notifications in Manchester increased. Requests for screening of pregnant women in contact with rubella also increased at that time, confirming the occurrence of a local outbreak (fig 2) . Requests for prevaccination screening also doubled in December 1983, when rubella was not prevalent. The rise began in the week of 28 Sixteen (59%) of the 27 women infected during 1984 were parous, giving an attack rate of 5% in the 320 parous women susceptible during 1984; the rate in the 787 susceptible nulliparous women was 1-4%. Two parous women had documented evidence of past adult vaccination (one with Almevax, one with Cendevax). Two had been screened in a previous pregnancy but had refused vaccine, while another had not been vaccinated post partum because she had refused contraception.
In 1983 acute rubella was confirmed in 30 pregnant women in the local population. Of the 21 infected during the first 16 weeks of pregnancy, 16 had a therapeutic abortion. Congenital infection was diagnosed in five infants, of whom one had symptoms at birth and a second was subsequently found to be deaf.
In both 1983 and 1984 most of the infections occurred in the April to June quarter (table IV) . In all, 4% of pregnant women in the area required serological investigation for contact or suspected infection with rubella during 1984.
Discussion
This study shows that in 1984 fewer than 3% of 40 000 pregnant women in the Manchester area were susceptible to rubella. By contrast, nearly 9% of men were susceptible, a figure similar to the 10% of pregnant women reported in Britain before vaccination began.'4 The difference in susceptibility between nulliparous women and men of the same age was greatest in the under 20 age group and must largely be due to the vaccination of schoolgirls. Immunity in younger women is likely to increase further, since in Manchester acceptance of vaccination by girls of 11 years has exceeded 90% since 1979.' The difference in susceptibility between men and nulliparous women too old to have been vaccinated at school indicates that vaccination before pregnancy has also had considerable effect. The prevalence of antibody in men increased with age, suggesting that acute rubella in men is not uncommon and must present a risk to non-immune pregnant women.
The impact of postpartum vaccination is reflected in the threefold difference in susceptibility between parous and nulliparous women of the same age. Although the greater exposure to infection in parous women may have been contributory, the effect of this must be small compared with that of postpartum vaccination, which in Central Manchester in 1981 was given to 90% of seronegative mothers before discharge.'5 In our study 85% of non-immune women were vaccinated in hospital, some hospitals exceeding the DHSS target of 90%. We found, however, that without the intervention of the study nurse few women would have been vaccinated after discharge, since there was no effective link between hospital and general practitioner. Further omissions included a lack of vaccination policy for women admitted for abortion or being treated for infertility.
An increase in requests from general practitioners for screening non-pregnant women reflected an immediate-though short lived -response to the national campaign, and local initiatives and rubella outbreaks produced a similar effect. Susceptibility to rubella among the non-pregnant women screened was three times that in the pregnant population; clearly screening non-pregnant women identifies many who have missed both school and adult vaccination. Over a quarter, however, were not subsequently vaccinated, and follow up by the laboratories increased the vaccination rate by only 5%. Routine pre-employment testing, which accounted for nearly half the requests for screening non-pregnant women, identified few susceptible women. Only half of these were subsequently vaccinated, confirming previous findings.5
The reduction in the number of susceptible women in the local pregnant population in recent years must have prevented many infections in pregnancy. Nevertheless, during the 1983-4 outbreaks in Manchester, both smaller than that of 1978, rubella was confirmed in over 2% of susceptible pregnant women. The risk was greatest when outbreaks were at their height; no infections were reported in the winter, when rubella was not prevalent. For nonimmune women the risk of infection was three times greater for those with children than for those in their first pregnancy. The large number of pregnant women who sought diagnostic investigation after contact shows the anxiety aroused when rubella is prevalent. Over 93% of those investigated proved to be immune, but this increase in laboratory work load is inevitable so long as the wild virus continues to circulate. The 57 infections in this study out of a total of nearly 700 reported to the Communicable Disease Surveillance Centre by laboratories in England and Wales in 1983-4-were diagnosed at the time of infection, so giving the woman the option of having her pregnancy terminated. Clearly the diagnosis and termination of infected pregnancies are still essential factors in preventing congenital rubella syndrome. In asymptomatic cases with no known contact, however, an affected baby may be the first sign.
The policy of selective vaccination in Britain has aimed at increasing immunity in the childbearing population rather than reducing the overall incidence of rubella. In the Manchester area a high degree of immunity has now been achieved through levels of school and postpartum vaccination approaching those recommended. Preliminary results from other laboratories participating in the study show immunity in excess of 97% in populations of pregnant women elsewhere in the country. Selective vaccination has had considerable effect, but it is clear that 1-2% of women will inevitably remain susceptible, either because they miss or refuse vaccination or because they fail to respond to vaccine. Our findings show the consequences of allowing wild rubella virus to circulate while even this small proportion of pregnant women remains susceptible.
Although this report relates to one area only, the implications are that even when the present policy is well implemented congenital rubella syndrome will not be eliminated and infection in pregnancy will continue at an unacceptable level. Vaccination of the target population should undoubtedly continue, but we believe that the policy should be supplemented by mass vaccination of infants and preschool children of both sexes to reduce circulation of the virus and thereby the risk of contact in pregnancy. The immediate and long term effects would depend both on the quality and duration of vaccine induced immunity and on the acceptance of vaccine in infancy and childhood. Discussion of these topics is outside the scope of this paper and will be presented elsewhere. If, however, the proposed additions were to be adopted the monitoring system described here would provide the means of assessing the results of the change in policy.
to an adequate level of skill that will be remembered over time? Does cardiopulmonary resuscitation really save lives?
In our experience community training schemes for cardiopulmonary resuscitation are the essential foundation for improving survival Several times at Brighton we heard the comment: "Seattle and King County, Washington, are the best places in the world to have a heart attack but the worst places in the world to have a faint!" Does harm occur when overzealous people administer cardiopulmonary resuscitation to people who are not in complete cardiac arrest-for example, victims of syncope and drug
